U.S. Cannabinoids Market Size, Share & Trends Analysis Report By Product Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG)), By Application (Inflammation, Pain Management), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment scope
                       1.1.2 Regional scope
                       1.1.3 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database:
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach: Commodity Flow Approach
                   1.7 Research Assumptions
                   1.8 List of Secondary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 U.S. Cannabinoids Market Variables, Trends, & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market
                   3.2 Regulatory Scenario
                   3.3 Market Dynamics
                       3.3.1 Market drivers analysis
                           3.3.1.1 Growing number of new entrants in the market leading to expansion in product availability
                           3.3.1.2 Increasing number of consumers opting for isolated cannabinoid products
                           3.3.1.3 Growing number of clinical studies on the use of cannabinoids for specific applications
                           3.3.1.4 Rising awareness about cannabinoid products and their use in health and wellness
                       3.3.2 Market restraint analysis
                           3.3.2.1 High price of cannabinoids-based products
                           3.3.2.2 Expensive extraction processes for cannabinoids
                           3.3.2.3 Absence of definite regulatory framework for minor cannabinoids
                           3.3.2.4 Limited research is hindering the growth of the cannabinoids market
                   3.4 U.S. Cannabinoids Market Analysis Tools
                       3.4.1 U.S. Cannabinoids Market - PESTLE Analysis
                       3.4.2 U.S. Cannabinoids Market - PORTER’S Analysis
                   3.5 COVID Impact Analysis
                   3.6 Supply Chain Analysis
                       3.6.1 Supply Chain Analysis - CBD Consumer Health Product
                   3.7 Product Adoption Pattern Analysis
                       3.7.1 Cannabidiol (CBD)
                       3.7.2 Tetrahydrocannabinol (THC)
                       3.7.3 Cannabinol (CBN)
                       3.7.4 Cannabidiolic Acid (CBDA)
                       3.7.5 Others
                           3.7.5.1 Cannabigerol (CBG)
                           3.7.5.2 Cannabichromene (CBC)
                   3.8 Biosynthetic Cannabinoids
                   3.9 Upcoming Trends in U.S. Minor Cannabinoids Market
                       3.9.1 Diversification Of Products:
                       3.9.2 Increased Availability Of Minor Cannabinoids:
                       3.9.3 More Brands Entering The Market:
                       3.9.4 Growing Demand For Natural Remedies:
                   3.10 TAM-SAM-SOM Analysis
                   3.11 Transcript of an industry KOL
                   3.12 Key Analysis from the Primary Respondents
Chapter 4 U.S. Cannabinoids Market Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
                   4.1 Definition and Scope
                   4.2 Product Type Market Share Analysis, 2022 & 2030
                   4.3 Segment Dashboard
                   4.4 U.S. Cannabinoids Market, by Product Type, 2018 to 2030
                   4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       4.5.1 Cannabidiol (CBD)
                           4.5.1.1 Cannabidiol (CBD) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.2 Tetrahydrocannabinol (THC)
                           4.5.2.1 Tetrahydrocannabinol (THC) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.3 Cannabinol (CBN)
                           4.5.3.1 Cannabinol (CBN) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.4 Cannabigerolic Acid (CBGA)
                           4.5.4.1 Cannabigerolic acid (CBGA) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.5 Cannabigerol (CBG)
                           4.5.5.1 Cannabigerol (CBG) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.6 Cannabichromene (CBC)
                           4.5.6.1 Cannabichromene (CBC) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.7 Tetrahydrocannabivarin (THCV)
                           4.5.7.1 Tetrahydrocannabivarin (THCV) market estimates and forecast, 2018 - 2030 (USD Million)
                       4.5.8 Others
                           4.5.8.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 U.S. Cannabinoids Market Segment Analysis, By Application 2018 - 2030 (USD Million)
                   5.1 Definition and Scope
                   5.2 Application Market Share Analysis, 2022 & 2030
                   5.3 Segment Dashboard
                   5.4 U.S. Cannabinoids Market, by Application, 2018 to 2030
                   5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       5.5.1 Inflammation
                           5.5.1.1 Inflammation market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.2 Pain Management
                           5.5.2.1 Pain management market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.3 Neurological Disorders
                           5.5.3.1 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.4 Cancer
                           5.5.4.1 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.5 Others
                           5.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 U.S. Cannabinoids Market - Competitive Analysis
                   6.1 Recent Developments & Impact Analysis, by Key Market Participants
                       6.1.2 Heat map analysis
                       6.1.3 Major Deals and Strategic Alliances Analysis
                           6.1.3.1 Joint Ventures
                           6.1.3.2 Licensing Agreements
                           6.1.3.3 Product Launches
                   6.2 Company Categorization
                       6.2.1 Innovators
                       6.2.2 Market Leaders
                   6.3 Company Market Position Analysis
                   6.4 Company Profiles
                       6.4.1 Mile High Labs
                           6.4.1.1 Company overview
                           6.4.1.2 Financial performance
                           6.4.1.3 Product benchmarking
                           6.4.1.4 Strategic Initiatives
                       6.4.2 Global Cannabinoids
                           6.4.2.1 Company overview
                           6.4.2.2 Financial performance
                           6.4.2.3 Product benchmarking
                           6.4.2.4 Strategic Initiatives
                       6.4.3 GenCanna
                           6.4.3.1 Company overview
                           6.4.3.2 Financial performance
                           6.4.3.3 Product benchmarking
                           6.4.3.4 Strategic Initiatives
                       6.4.4 CBD Inc.
                           6.4.4.1 Company overview
                           6.4.4.2 Financial performance
                           6.4.4.3 Product benchmarking
                           6.4.4.4 Strategic Initiatives
                       6.4.5 Precision Plant Molecules
                           6.4.5.1 Company overview
                           6.4.5.2 Financial performance
                           6.4.5.3 Product benchmarking
                           6.4.5.4 Strategic Initiatives
                       6.4.6 Rhizo Sciences
                           6.4.6.1 Company overview
                           6.4.6.2 Financial performance
                           6.4.6.3 Product benchmarking
                           6.4.6.4 Strategic Initiatives
                       6.4.7 LaurelCrest
                           6.4.7.1 Company overview
                           6.4.7.2 Financial performance
                           6.4.7.3 Product benchmarking
                           6.4.7.4 Strategic initiatives
                       6.4.8 Fresh Bros Hemp Company
                           6.4.8.1 Company overview
                           6.4.8.2 Financial performance
                           6.4.8.3 Product benchmarking
                           6.4.8.4 Strategic initiatives
                       6.4.9 BulKanna
                           6.4.9.1 Company overview
                           6.4.9.2 Financial performance
                           6.4.9.3 Product benchmarking
                           6.4.9.4 Strategic initiatives
                       6.4.10 High-Purity Natural Products
                           6.4.10.1 Company overview
                           6.4.10.2 Financial performance
                           6.4.10.3 Product benchmarking
                           6.4.10.4 Strategic initiatives
                       6.4.11 Zero Point Extraction, LLC
                           6.4.11.1 Company overview
                           6.4.11.2 Financial performance
                           6.4.11.3 Product benchmarking
                           6.4.11.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Key companies undergoing collaboration
Table 4 Key companies undergoing partnership
Table 5 Key companies undergoing product launch
Table 6 Key companies undergoing new products/services

List of Figures

Fig. 1 U.S. cannabinoids market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 U.S. cannabinoids market: Product type movement analysis
Fig. 17 U.S. cannabinoids market: Product type segment dashboard
Fig. 18 U.S. cannabinoids market product type outlook: Key takeaways
Fig. 19 Tetrahydrocannabinol (THC) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Cannabidiol (CBD) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Cannabigerol (CBG) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Cannabichromene (CBC) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Cannabinol (CBN) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Tetrahydrocannabivarin (THCV) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Cannabigerolic Acid (CBGA) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 U.S. cannabinoids market: Application movement analysis
Fig. 28 U.S. cannabinoids market: Application segment dashboard
Fig. 29 U.S. cannabinoids market Application outlook: Key takeaways
Fig. 30 Inflammation U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Pain Management U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Neurological Disorders U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Cancer U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Others U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Heat map analysis
Fig. 36 Market differentiators